SS
TPST icon

SBI Securities’s Tempest Therapeutics TPST Stock Holding History

SBI Securities’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62 Hold
56
– – ﹤0.01% 3625
2026
Q1 		$92 Hold
56
– – ﹤0.01% 3428
2025
Q4 		$161 Hold
56
– – ﹤0.01% 3280
2025
Q3 		$576 Hold
56
– – ﹤0.01% 2911
2025
Q2 		$381 Sell
56
-3
-5% -$21 ﹤0.01% 3072
2025
Q1 		$566 Hold
59
– – ﹤0.01% 2819
2024
Q4 		$640 Buy
+59
New +$762 ﹤0.01% 2804

Other funds holding TPST

PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

SBI Securities's TPST Position: Q2 2026 in Review

SBI Securities held its Tempest Therapeutics (TPST) position steady in Q2 2026 at 56 shares worth $62. The position accounts for ﹤0.01% of the portfolio, ranked #3625.

SBI Securities first reported a position in TPST in Q4 2024 and has held it in 7 quarters since. The position peaked at $640 in Q4 2024. 3 funds tracked by Wall St. Rank hold TPST as of Q2 2026.

  • SBI Securities held 56 shares of Tempest Therapeutics worth $62 as of Q2 2026.
  • SBI Securities left its Tempest Therapeutics share count unchanged in Q2 2026.
  • Tempest Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3625 holding.
  • SBI Securities first reported a position in Tempest Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Tempest Therapeutics position peaked at $640 in Q4 2024.
  • 3 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.